# Plexiform Fibromyxoma with MALAT1–GLI1 Fusion with Limited Myxoid Stroma, Aberrant KIT Expression, and Diffuse D2-40 Expression: A Case Report

**Authors:** Kotaro Watanabe, Kazuhito Tanaka, Kohei Ohkura, Kojiro Eto, Satoshi Ida, Kohei Yamashita, Yushi Kawakami, Keita Kai, Hidetaka Yamamoto, Yasuhito Tanaka, Masaaki Iwatsuki, Yoshiki Mikami

PMC · DOI: 10.3390/diagnostics16060879 · 2026-03-16

## TL;DR

A rare case of gastric plexiform fibromyxoma with unique features like limited myxoid stroma and specific gene fusion is reported, aiding in distinguishing it from similar tumors.

## Contribution

This case report expands the known morphologic and immunophenotypic features of plexiform fibromyxoma.

## Key findings

- A gastric tumor case showed limited myxoid stroma and aberrant KIT expression, complicating diagnosis.
- Molecular analysis confirmed MALAT1–GLI1 fusion, supporting a diagnosis of plexiform fibromyxoma.
- Diffuse D2-40 expression was observed, suggesting potential diagnostic utility in similar cases.

## Abstract

Background and Clinical Significance: Plexiform fibromyxoma (PFM) is a rare benign gastric mesenchymal neoplasm characterized by multinodular plexiform growth of bland spindle cells in a myxoid or fibromyxoid stroma. We report a case of the cellular form of PFM with limited myxoid stroma and aberrant KIT expression, resulting in diagnostic difficulty by biopsy. Case Presentation: A 59-year-old woman presented with a slowly enlarging 15 mm gastric antral submucosal tumor. A resected specimen by laparoscopic and endoscopic cooperative surgery revealed spindle cell proliferation forming plexiform nodules with a myxoid background in limited areas. Positive immunoreactivity of a subset of spindle cells for KIT suggested a diagnosis of gastrointestinal stromal tumor (GIST), although DOG1 was negative. In addition, diffuse staining for CD10, smooth muscle actin, and D2-40 was confusing. MALAT1::GLI1 fusion was detected by next-generation sequencing analysis. Consequently, a diagnosis of PFM was established. Conclusions: This case expands the morphologic and immunophenotypic spectrum of PFM and indicates the possible diagnostic utility and biological significance of D2-40 expression. Although molecular confirmation of MALAT1::GLI1 fusion is definitive for the diagnosis of PFM, the findings of the present case may aid diagnosis in challenging cases that mimic GIST.

## Linked entities

- **Genes:** MALAT1 (metastasis associated lung adenocarcinoma transcript 1) [NCBI Gene 378938], GLI1 (GLI family zinc finger 1) [NCBI Gene 2735], KIT (KIT proto-oncogene, receptor tyrosine kinase) [NCBI Gene 3815], ANO1 (anoctamin 1) [NCBI Gene 55107], MME (membrane metalloendopeptidase) [NCBI Gene 4311], PDPN (podoplanin) [NCBI Gene 10630]
- **Diseases:** gastrointestinal stromal tumor (MONDO:0011719)

## Full-text entities

- **Genes:** MME (membrane metalloendopeptidase) [NCBI Gene 4311] {aka CALLA, CD10, CMT2T, NEP, SCA43, SFE}, ANO1 (anoctamin 1) [NCBI Gene 55107] {aka DOG1, INDMS, MYMY7, ORAOV2, TAOS2, TMEM16A}, MALAT1 (metastasis associated lung adenocarcinoma transcript 1) [NCBI Gene 378938] {aka HCN, LINC00047, NCRNA00047, NEAT2, PRO2853, miPEP-52}, GLI1 (GLI family zinc finger 1) [NCBI Gene 2735] {aka GLI, PAPA8, PPD1}, KIT (KIT proto-oncogene, receptor tyrosine kinase) [NCBI Gene 3815] {aka C-Kit, CD117, MASTC, PBT, SCFR}
- **Diseases:** PFM (MESH:D005350), GIST (MESH:D046152), Myxoid Stroma (MESH:D045888), gastric mesenchymal neoplasm (MESH:D013274), gastric antral submucosal tumor (MESH:D020252)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13025454/full.md

---
Source: https://tomesphere.com/paper/PMC13025454